Historical record - last NADAC effective date: 8/19/2020

Product Information

RITONAVIR 100 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $1.7776 per EA under NDC 65162006106. Its NADAC has been published 97 times since Oct 31, 2018.

FDA first approved this application on Sep 17, 2018.

RITONAVIR 100 MG TABLET

Ritonavir
$1.7776per EA

Strength

100 mg/1

NDC

65162006106

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2020

Active Ingredients

RITONAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA208890

FDA Approved

9/17/2018

On Market Since

9/21/2018

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
P-Glycoprotein Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inducers

Price Statistics

The NADAC for RITONAVIR 100 MG TABLET has been published 97 times since Oct 31, 2018, and over the history we have for it it has declined 64.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7776 per EA
All-time high$5.0234 (Nov 14, 2018)
All-time low$1.5897 (Jul 22, 2020)
Median price$1.8322
Average price$2.0488
Largest weekly change-42.6% (Dec 19, 2018)
Weeks tracked97
Tracking sinceOct 31, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-64.6%

Last surveyed Sep 2, 2020 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RITONAVIR 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RITONAVIR 100 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $1.7776 per EA (NDC 65162006106), effective Sep 2, 2020.

How has the price of RITONAVIR 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for RITONAVIR 100 MG TABLET has declined 64.6%. It has been tracked across 97 weekly CMS publications since Oct 31, 2018.

What are the highest and lowest recorded NADAC prices for RITONAVIR 100 MG TABLET?

Since Oct 31, 2018, the NADAC for RITONAVIR 100 MG TABLET has ranged from a low of $1.5897 (Jul 22, 2020) to a high of $5.0234 (Nov 14, 2018), with a median of $1.8322 per EA.

Are there cheaper alternatives to RITONAVIR 100 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RITONAVIR 100 MG TABLET, is $0.6067 per EA — about 66% below RITONAVIR 100 MG TABLET.

Who manufactures RITONAVIR 100 MG TABLET?

RITONAVIR 100 MG TABLET (NDC 65162006106) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.